New Zealand’s cancer patients
may soon have access to
melanoma treatment Keytruda
(pembrolizumab) with the country’s
Pharmaceutical Management
Agency, Pharmac, issuing a
consultation proposal to fund the
product from 01 Sep.
This follows Pharmac’s earlier
decision to fund Keytruda rival
Opdivo from today.
The agency said it “has worked
constructively with supplier,
Merck Sharp & Dohme (MSD) to
reach a favourable commercial
arrangement”.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Jul 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Jul 16
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
THE University of South Australia has released a new study to help healthcare workers better support women with persistent pelvic pain, including symptoms that are suggestive of gynaecological, lower urinary tract, bowel, sexual, and pelvic floor dysfunction.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.